Suppr超能文献

治疗药物监测的最佳实践。

Best practice in therapeutic drug monitoring.

作者信息

Gross A S

机构信息

Department of Clinical Pharmacology, Royal North Shore Hospital, St Leonards NSW, Australia.

出版信息

Br J Clin Pharmacol. 1998 Aug;46(2):95-9. doi: 10.1046/j.1365-2125.1998.00770.x.

Abstract

It is the goal of Therapeutic Drug Monitoring (TDM) to use drug concentrations to manage a patient's medication regimen and optimise outcome. Limited resources require that drug assays should only be performed when they do contribute to patient management. For this to be the case a therapeutic drug monitoring service has a far greater role than just therapeutic drug measuring. This article describes the roles and functions of a Best Practice TDM service. The features which can and should be strived for in each step of the TDM process-the decision to request a drug level, the biological sample, the request, laboratory measurement, communication of results by the laboratory, clinical interpretation and therapeutic management-are discussed.

摘要

治疗药物监测(TDM)的目标是利用药物浓度来管理患者的用药方案并优化治疗效果。资源有限,这就要求仅在药物检测有助于患者管理时才进行检测。要实现这一点,治疗药物监测服务的作用远不止于药物检测。本文描述了最佳实践TDM服务的作用和功能。文中讨论了TDM过程每个步骤中能够且应该追求的特征,即申请药物浓度检测的决定、生物样本、申请、实验室检测、实验室结果传达、临床解读以及治疗管理。

相似文献

1
Best practice in therapeutic drug monitoring.治疗药物监测的最佳实践。
Br J Clin Pharmacol. 1998 Aug;46(2):95-9. doi: 10.1046/j.1365-2125.1998.00770.x.
2
Best practice in therapeutic drug monitoring.治疗药物监测的最佳实践。
Br J Clin Pharmacol. 2001;52 Suppl 1(Suppl 1):5S-10S. doi: 10.1046/j.1365-2125.2001.0520s1005.x.
3
Therapeutic drug monitoring in a developing country: an overview.发展中国家的治疗药物监测:概述
Br J Clin Pharmacol. 2001;52 Suppl 1(Suppl 1):103S-108S. doi: 10.1046/j.1365-2125.2001.0520s1103.x.

引用本文的文献

6
Bioanalytical technologies using temperature-responsive polymers.使用温度响应性聚合物的生物分析技术。
Anal Sci. 2024 May;40(5):827-841. doi: 10.1007/s44211-024-00545-3. Epub 2024 Apr 7.
8
Therapeutic Drug Monitoring by Pharmacists: Does It Reduce Costs.药剂师进行的治疗药物监测:它能降低成本吗?
Glob J Qual Saf Healthc. 2020 May 21;3(2):69-71. doi: 10.36401/JQSH-19-40. eCollection 2020 May.

本文引用的文献

1
Indications for plasma drug monitoring in patients with epilepsy. Implications for reducing costs.
Pharmacoeconomics. 1997 Apr;11(4):343-9. doi: 10.2165/00019053-199711040-00005.
4
Drug monitoring in nonconventional biological fluids and matrices.非常规生物流体和基质中的药物监测。
Clin Pharmacokinet. 1996 Mar;30(3):211-28. doi: 10.2165/00003088-199630030-00003.
5
Antiepileptic drug monitoring: a reappraisal.抗癫痫药物监测:重新评估
Epilepsia. 1995;36 Suppl 5:S22-9. doi: 10.1111/j.1528-1157.1995.tb06006.x.
6
Measurement and analysis of unbound drug concentrations.游离药物浓度的测定与分析。
Clin Pharmacokinet. 1996 Jun;30(6):445-62. doi: 10.2165/00003088-199630060-00003.
9
Concentration- or effect-controlled clinical trials with sparse data.
Clin Pharmacol Ther. 1994 Jul;56(1):1-8. doi: 10.1038/clpt.1994.93.
10
Therapeutic drug monitoring and patient outcome. A review of the issues.
Clin Pharmacokinet. 1994 Sep;27(3):169-74. doi: 10.2165/00003088-199427030-00001.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验